City of Hope has so many breakthroughs in cancer, diabetes and HIV/AIDS - and so many stories - that we've tailored our blog, Breakthroughs, to provide something for every reader. Whether the breakthroughs are about medical research, treatment advances or personal triumphs, they're all connected.
March 7, 2017 | Samantha Bonar
Doctors nationwide are mourning the loss of Thomas E. Starzl, the surgeon and researcher who pioneered the liver transplant and the medications that made the procedure successful in the long term. Starzl died on March 4 at his home in Pittsburg at age 90.
November 1, 2016 | Abe Rosenberg
City of Hope is a leader in liver cancer detection and treatment. Here, surgeon and researcher Susanne Gray Warner, M.D. explains how to better understand how this cancer works; where it comes from; and how it is treated.
December 24, 2015 | Veronique de Turenne
By the end of 2016, treatment for liver cancer could look much different than it does now. Progress in the evolving field of immunotherapy and the emerging field of viral-based gene therapy herald a promising new era in the field of liver cancer.
October 27, 2015 | Valerie Howard
Although liver cancer is considered relatively rare, striking an estimated 33,000 Americans each year - mostly men over the age of 45 - it is extremely challenging to treat if not caught early. At City of Hope, expert researchers and doctors such as Laleh Melstrom, M.D., M.S, are working tirelessly to advance liver cancer research and treatment, in order to improve early detection and survival rates.
March 8, 2015 | Darrin Joy
Liver cancer is terribly difficult to cure. Despite significant treatment advances, five-year survival rates remain at about 15 percent overall — and they rapidly approach zero when the disease is found too late.
January 1, 2015 | Tami Dennis
Every year, researchers make gains in the understanding of cancer, and physicians make gains in the treatment of cancer. As a result, every year, more cancer patients survive their disease. In 2015, cancer research will move forward in ways both high-profile and little-heralded.
December 24, 2014 | Tami Dennis
Yuman Fong, M.D., is an internationally recognized expert in hepatobiliary cancer – that is liver cancer, pancreatic cancer, gallbladder cancer and cancer of the bile ducts. He's also renowned for his use of genetically modified viruses to combat malignant disease, is a pioneer in the operating room and the laboratory, is the author of more than 600 peer-reviewed articles and 11 textbooks, and is the chair of the Department of Surgery at City of Hope.
November 6, 2014 | City of Hope
Cancer that spreads to the liver poses a significant threat to patients, and a great challenge to surgeons. The organ’s anatomical complexity and its maze of blood vessels make removal of tumors difficult, even for specialized liver cancer surgeons.
June 18, 2014 | Nicole White
Advances in the fight against cancer have many measures. Grant dollars received. Papers published. New targets for medication discovered. New therapies unveiled. These all matter because they lead to the ultimate measure of success in treating cancer: people alive and families intact.
June 10, 2014 | Nicole White
Less invasive treatments. More cures. Yuman Fong, M.D. , chair of the Department of Surgery at City of Hope, has adopted this as more than a mantra. He’s made it his life’s work. Penning the leading textbooks and manuals in liver surgery, delving into gene therapy to find innovative new approaches to use viruses to attack cancer, and exploring robotic means to improve surgeries and make them less invasive, Fong doesn’t limit himself to a single medical discipline in his quest to fight cancer.